Predominant nocturnal acid reflux in patients with Los Angeles grade C and D reflux esophagitis

被引:100
作者
Adachi, K [1 ]
Fujishiro, H [1 ]
Katsube, T [1 ]
Yuki, M [1 ]
Ono, M [1 ]
Kawamura, A [1 ]
Rumi, MAK [1 ]
Watanabe, M [1 ]
Kinoshita, Y [1 ]
机构
[1] Shimane Med Univ, Dept Internal Med 2, Izumo, Shimane 6938501, Japan
关键词
endoscopy; nocturnal acid reflux; nocturnal gastric acid breakthrough; pH monitoring; reflux esophagitis;
D O I
10.1046/j.1440-1746.2001.02617.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims: Nocturnal gastric acid breakthrough (NAB) is defined as an intragastric pH < 4.0 lasting more than 1 h during the night in patients taking a proton pump inhibitor (PPI). Gastroesophageal reflux disease (GERD) patients with nocturnal gastroesophageal acid reflux accompanied by NAB are thought to be refractory to PPI treatment. The aim of this study was to endoscopically identify the patients with predominant nocturnal gastroesophageal acid reflux. Methods: The subjects were 37 patients with erosive reflux esophagitis (Los Angeles classification (LA) grade A, 12; B, 10; C, eight; and D, seven cases) and a control group of 20 patients without esophagitis. The results of ambulatory 24 h gastric and esophageal pH monitoring were compared among different grades of esophagitis. Results: Gastroesophageal reflux during 24 h in patients with high-grade esophagitis was more frequent than for patients with low-grade esophagitis or no esophagitis. Although the length of esophageal acid exposure (percentage time with pH < 4.0) in patients with grade A or without esophagitis was longer in the daytime, that in patients with grades C and D was longer during the night. The reason for the delayed nocturnal acid exposure was the longer nocturnal acid clearance in high-grade reflux esophagitis. Conclusions: Nocturnal exposure of the esophagus to acid occurs frequently in patients with LA grades C and D esophagitis. Thus, the existence of NAB with resulting nocturnal acid reflux should be considered when the patient with high-grade esophagitis shows resistance to PPI treatment. (C) 2001 Blackwell Science Asia Pty Ltd.
引用
收藏
页码:1191 / 1196
页数:6
相关论文
共 25 条
[1]   CYP2C19 genotype status and intragastric pH during dosing with lansoprazole or rabeprazole [J].
Adachi, K ;
Katsube, T ;
Kawamura, A ;
Takashima, T ;
Yuki, M ;
Amano, K ;
Ishihara, S ;
Fukuda, R ;
Watanabe, M ;
Kinoshita, Y .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (10) :1259-1266
[2]   Role of hiatus hernia and gastric mucosal atrophy in the development of reflux esophagitis in the elderly [J].
Amano, K ;
Adachi, K ;
Katsube, T ;
Watanabe, M ;
Kinoshita, Y .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (02) :132-136
[3]   ROLE OF GASTRIC-ACID SUPPRESSION IN THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE [J].
BELL, NJV ;
HUNT, RH .
GUT, 1992, 33 (01) :118-124
[4]  
Dekkers CPM, 1999, ALIMENT PHARM THERAP, V13, P49
[5]   MECHANISMS OF GASTRO-ESOPHAGEAL REFLUX IN PATIENTS WITH REFLUX ESOPHAGITIS [J].
DODDS, WJ ;
DENT, J ;
HOGAN, WJ ;
HELM, JF ;
HAUSER, R ;
PATEL, GK ;
EGIDE, MS .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (25) :1547-1552
[6]  
Fouad YM, 1999, ALIMENT PHARM THERAP, V13, P1467
[7]   HOW WELL CAN QUANTITATIVE 24-HOUR INTRAESOPHAGEAL PH MONITORING DISTINGUISH VARIOUS DEGREES OF REFLUX DISEASE [J].
GHILLEBERT, G ;
DEMEYERE, AM ;
JANSSENS, J ;
VANTRAPPEN, G .
DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (06) :1317-1324
[8]   SPONTANEOUS TRANSIENT LOWER ESOPHAGEAL SPHINCTER RELAXATIONS - A TARGET FOR TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE [J].
JANSSENS, J ;
SIFRIM, D .
GASTROENTEROLOGY, 1995, 109 (05) :1703-1706
[9]  
KASAPIDIS P, 1993, AM J GASTROENTEROL, V88, P1893
[10]   Helicobacter pylori infection influences nocturnal gastric acid breakthrough [J].
Katsube, T ;
Adachi, K ;
Kawamura, A ;
Amano, K ;
Uchida, Y ;
Watanabe, M ;
Kinoshita, Y .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (08) :1049-1056